story of the week
Inotuzumab Ozogamicin for Acute Lymphoblastic Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Inotuzumab Ozogamicin Versus Standard Therapy for Acute Lymphoblastic Leukemia
N. Engl. J. Med 2016 Jun 12;[EPub Ahead of Print], HM Kantarjian, DJ DeAngelo, M Stelljes, G Martinelli, M Liedtke, W Stock, N Gökbuget, S O'Brien, K Wang, T Wang, ML Paccagnella, B Sleight, E Vandendries, AS AdvaniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.